Basic information
Biomarker: lamin A
Histology type: endometrial carcinoma
Stage: low grade
Cohort characteristics
Country: Italy
Region: Rome
Study type: retrospective study
Followed up time :
Subgroup 1 name : G1 EECs
Subgroup 1 number: 29
Subgroup 2 name: G2-G3 EECs
Subgroup 2 number: 49
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
100 | EC | 87 | benign tissue specimens | 13 |
Sample information
Conclusion: We identified lamin A expression levels as novel potential biomarkers useful to identify G1 ECs patients with risk of recurrence.
Sample type : tissue
Sample method: quantitative PCR / western blotting /immunoblotting
Expression pattern : expression
Disease information
Statictics: Mean ;Range
Cohort age: 63;42-88
Subgroup 1 age: 58;42-76
Subgroup 2 age: 66;43-88
Related information
Funtion Uniprot: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends (PubMed:31548606). Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920).13 Publications Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.
UniProt ID: P02545
UniProt Link: https://www.uniprot.org/uniprotkb/P02545/entry
Molecular function from UniProt:
Tissue specificity from UniProt: In the arteries, prelamin-A/C accumulation is not observed in young healthy vessels but is prevalent in medial vascular smooth muscle cells (VSMCs) from aged individuals and in atherosclerotic lesions, where it often colocalizes with senescent and degenerate VSMCs. Prelamin-A/C expression increases with age and disease. In normal aging, the accumulation of prelamin-A/C is caused in part by the down-regulation of ZMPSTE24/FACE1 in response to oxidative stress.
Subcellular UniProt: #Intermediate filament #Nucleus
Alternative name from UniProt:
Miscellaneous: There are three types of lamins in human cells: A, B, and C. The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.
Recommended name: Prelamin-A/C
Gene name from HGNC: LMNA (CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1)
HPA class: Cancer-related genes Disease related genes Human disease related genes Plasma proteins factors Transporters
AlphaFold DB: P02545
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P02545
HPA link: https://www.proteinatlas.org/ENSG00000160789-LMNA
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Distinct nuclear membrane expression in all cell types.
Single cell type specificity Cell type enhanced (Langerhans cells)
Immune cell specificity: Immune cell enhanced (myeloid DC, T-reg)
Subcellular summary HPA Located in Nuclear speckles
Cancer prognostic summary HPA Gene product is not prognostic
Pathology link: https://www.proteinatlas.org/ENSG00000160789-LMNA/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000160789-LMNA/pathology/endometrial+cancer
Phenotype ID: 181350
Disease: Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2)
Note1: The disease is caused by variants affecting the gene represented in this entry
OMIM: 150330
OMIM link1: https://www.omim.org/entry/181350
OMIM link2: https://www.omim.org/entry/150330
HGNC ID: HGNC:6636
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6636